PDEX Stock Overview
Designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Pro-Dex, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$19.65 |
52 Week High | US$22.99 |
52 Week Low | US$14.51 |
Beta | 0.55 |
1 Month Change | 5.99% |
3 Month Change | 14.85% |
1 Year Change | 6.10% |
3 Year Change | -42.73% |
5 Year Change | 64.85% |
Change since IPO | 261.38% |
Recent News & Updates
Investors Can Find Comfort In Pro-Dex's (NASDAQ:PDEX) Earnings Quality
Feb 16Here's Why Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt Responsibly
Feb 14Recent updates
Investors Can Find Comfort In Pro-Dex's (NASDAQ:PDEX) Earnings Quality
Feb 16Here's Why Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt Responsibly
Feb 14Pro-Dex, Inc.'s (NASDAQ:PDEX) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jan 24Pro-Dex (NASDAQ:PDEX) Has A Pretty Healthy Balance Sheet
May 20Pro-Dex (NASDAQ:PDEX) Could Be Struggling To Allocate Capital
Oct 05Pro-Dex: Growth Trends In Earnings, Return On Investment Contracting
Sep 26When Should You Buy Pro-Dex, Inc. (NASDAQ:PDEX)?
Sep 20Pro-Dex GAAP EPS of $0.38, revenue of $12.61M
Aug 25Is Now The Time To Look At Buying Pro-Dex, Inc. (NASDAQ:PDEX)?
May 10Is Pro-Dex (NASDAQ:PDEX) Using Too Much Debt?
Apr 21Pro-Dex (NASDAQ:PDEX) Is Doing The Right Things To Multiply Its Share Price
Mar 14Is Pro-Dex, Inc. (NASDAQ:PDEX) Potentially Undervalued?
Feb 09We Think Pro-Dex (NASDAQ:PDEX) Is Taking Some Risk With Its Debt
Nov 17Is It Too Late To Consider Buying Pro-Dex, Inc. (NASDAQ:PDEX)?
Aug 29A History Of Strong Growth Rates: Pro-Dex On Sale
Aug 25The Return Trends At Pro-Dex (NASDAQ:PDEX) Look Promising
May 18What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?
Mar 29Is Weakness In Pro-Dex, Inc. (NASDAQ:PDEX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 15The Pro-Dex (NASDAQ:PDEX) Share Price Is Up 732% And Shareholders Are Delighted
Feb 26Independent Director William Farrell Just Sold A Bunch Of Shares In Pro-Dex, Inc. (NASDAQ:PDEX)
Feb 13We Like These Underlying Trends At Pro-Dex (NASDAQ:PDEX)
Feb 08Pro-Dex EPS misses by $0.27, misses on revenue
Feb 04Is Pro-Dex (NASDAQ:PDEX) A Risky Investment?
Jan 25What Is The Ownership Structure Like For Pro-Dex, Inc. (NASDAQ:PDEX)?
Jan 11How Much Are Pro-Dex, Inc. (NASDAQ:PDEX) Insiders Taking Off The Table?
Dec 28With EPS Growth And More, Pro-Dex (NASDAQ:PDEX) Is Interesting
Dec 14What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?
Nov 30Shareholder Returns
PDEX | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0.3% | 1.1% | 1.2% |
1Y | 6.1% | 4.2% | 27.7% |
Return vs Industry: PDEX exceeded the US Medical Equipment industry which returned 4.2% over the past year.
Return vs Market: PDEX underperformed the US Market which returned 27.7% over the past year.
Price Volatility
PDEX volatility | |
---|---|
PDEX Average Weekly Movement | 4.4% |
Medical Equipment Industry Average Movement | 8.3% |
Market Average Movement | 5.9% |
10% most volatile stocks in US Market | 16.2% |
10% least volatile stocks in US Market | 2.8% |
Stable Share Price: PDEX has not had significant price volatility in the past 3 months.
Volatility Over Time: PDEX's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1978 | 146 | Rick Van Kirk | www.pro-dex.com |
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries.
Pro-Dex, Inc. Fundamentals Summary
PDEX fundamental statistics | |
---|---|
Market cap | US$65.49m |
Earnings (TTM) | US$2.04m |
Revenue (TTM) | US$49.46m |
32.9x
P/E Ratio1.4x
P/S RatioIs PDEX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PDEX income statement (TTM) | |
---|---|
Revenue | US$49.46m |
Cost of Revenue | US$35.64m |
Gross Profit | US$13.82m |
Other Expenses | US$11.78m |
Earnings | US$2.04m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.60 |
Gross Margin | 27.94% |
Net Profit Margin | 4.13% |
Debt/Equity Ratio | 38.0% |
How did PDEX perform over the long term?
See historical performance and comparison